Showing results (1-10 of 236) with videos related to
Sort By:
Pageof 24
Trends in Molecular Medicine|June 7, 2005
Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathyTaku Okazaki, Tasuku HonjoInternational Immunology|July 4, 2007
PD-1 and PD-1 ligands: from discovery to clinical applicationTaku Okazaki, Tasuku HonjoCell|February 14, 2006
Rejuvenating exhausted T cells during chronic viral infectionTaku Okazaki, Tasuku HonjoTrends in Immunology|February 28, 2006
The PD-1-PD-L pathway in immunological toleranceTaku Okazaki, Tasuku HonjoCurrent Opinion in Immunology|November 5, 2002
New regulatory co-receptors: inducible co-stimulator and PD-1Taku Okazaki, Yoshiko Iwai, Tasuku HonjoProceedings of the National Academy of Sciences of the United States of America|February 27, 2008
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD miceTaku Yoshida, Fang Jiang, Tasuku Honjo, et al.The Journal of Experimental Medicine|July 9, 2003
PD-1 inhibits antiviral immunity at the effector phase in the liverYoshiko Iwai, Seigo Terawaki, Masaya Ikegawa, et al.Nature Immunology|November 19, 2013
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical applicationTaku Okazaki, Shunsuke Chikuma, Yoshiko Iwai, et al.Proceedings of the National Academy of Sciences of the United States of America|September 10, 2002
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockadeYoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka, et al.Proceedings of the National Academy of Sciences of the United States of America|August 10, 2005
Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetesJian Wang, Taku Yoshida, Fumio Nakaki, et al.Pageof 24